Nada A. A. M. Aziz

Design, synthesis, <i>in silico</i> docking, ADMET and anticancer evaluations of thiazolidine-2,4-diones bearing heterocyclic rings as dual VEGFR-2/EGFR^T790M tyrosine kinase inhibitors

Nada A. A. M. Aziz, Riham F. George, Khaled El‐Adl et al. · RSC Advances · 2022 · 42 citations · Full text

Exploration of thiazolidine‐2,4‐diones as tyrosine kinase inhibitors: Design, synthesis, ADMET, docking, and antiproliferative evaluations

Nada A. A. M. Aziz, Riham F. George, Khaled El‐Adl et al. · Archiv der Pharmazie · 2022 · 25 citations

Design, synthesis, and docking of novel thiazolidine‐2,4‐dione multitarget scaffold as new approach for cancer treatment

Noura S. Hanafy, Nada A. A. M. Aziz, Sanadelaslam S. A. El‐Hddad et al. · Archiv der Pharmazie · 2023 · 22 citations · Full text